An Interventional, Single Arm, Phase I/IIa Clinical Trial to Investigate the Efficacy and Safety of APZ2 on Wound Healing of Chronic Venous Ulcer (CVU)

Trial Profile

An Interventional, Single Arm, Phase I/IIa Clinical Trial to Investigate the Efficacy and Safety of APZ2 on Wound Healing of Chronic Venous Ulcer (CVU)

Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 13 Nov 2017

At a glance

  • Drugs APZ 2 (Primary)
  • Indications Varicose ulcer
  • Focus Adverse reactions; First in man; Therapeutic Use
  • Sponsors RHEACELL
  • Most Recent Events

    • 07 Nov 2017 Planned End Date changed from 1 Dec 2018 to 1 Apr 2019.
    • 07 Nov 2017 Planned primary completion date changed from 1 Dec 2018 to 1 Apr 2019.
    • 25 Sep 2017 The trial has been suspended in Germany.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top